GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Invitae Corp (FRA:IV8) » Definitions » Cyclically Adjusted Price-to-FCF

Invitae (FRA:IV8) Cyclically Adjusted Price-to-FCF : (As of Jun. 07, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Invitae Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Invitae Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Invitae's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invitae Cyclically Adjusted Price-to-FCF Chart

Invitae Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Invitae Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Invitae's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, Invitae's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invitae's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Invitae's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Invitae's Cyclically Adjusted Price-to-FCF falls into.



Invitae Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Invitae's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2023 is calculated as:

For example, Invitae's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-0.234/129.8595*129.8595
=-0.234

Current CPI (Sep. 2023) = 129.8595.

Invitae Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201312 -0.406 98.326 -0.536
201403 -0.440 99.695 -0.573
201406 -0.577 100.560 -0.745
201409 -0.523 100.428 -0.676
201412 -0.500 99.070 -0.655
201503 -1.045 99.621 -1.362
201506 -0.631 100.684 -0.814
201509 -0.653 100.392 -0.845
201512 -0.630 99.792 -0.820
201603 -0.703 100.470 -0.909
201606 -0.586 101.688 -0.748
201609 -0.557 101.861 -0.710
201612 -0.563 101.863 -0.718
201703 -0.516 102.862 -0.651
201706 -0.452 103.349 -0.568
201709 -0.444 104.136 -0.554
201712 -0.548 104.011 -0.684
201803 -0.519 105.290 -0.640
201806 -0.341 106.317 -0.417
201809 -0.235 106.507 -0.287
201812 -0.201 105.998 -0.246
201903 -0.347 107.251 -0.420
201906 -0.378 108.070 -0.454
201909 -0.393 108.329 -0.471
201912 -0.497 108.420 -0.595
202003 -0.601 108.902 -0.717
202006 -0.464 108.767 -0.554
202009 -0.418 109.815 -0.494
202012 -0.559 109.897 -0.661
202103 -0.415 111.754 -0.482
202106 -0.448 114.631 -0.508
202109 -0.702 115.734 -0.788
202112 -0.761 117.630 -0.840
202203 -0.669 121.301 -0.716
202206 -0.615 125.017 -0.639
202209 -0.595 125.227 -0.617
202212 -0.336 125.222 -0.348
202303 -0.134 127.348 -0.137
202306 -0.197 128.729 -0.199
202309 -0.234 129.860 -0.234

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Invitae  (FRA:IV8) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Invitae Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Invitae's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Invitae (FRA:IV8) Business Description

Traded in Other Exchanges
Address
1400 16th Street, San Francisco, CA, USA, 94103
Invitae Corp operates as a genetic information company in diagnostic and research industry. The company's tests include multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders and other hereditary conditions.

Invitae (FRA:IV8) Headlines

No Headlines